| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| chlorhexidingluconat pink 0,5 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat blå 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat pink 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat + natriumnitrit 0,5 %/0,1 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Chlorhexidingluconat 0,5 % i 70 % IMS, til kirurgisk desinfektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| præparat til fjernelse af ørevoks |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidinpræparat til orofaryngal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing cetrimide and chlorhexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Chlorhexidingluconat i IMS |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| zink til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| permethrin 5 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| præparater til orofaryngal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 2 % + isopropylalkohol 70 % svamp til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| dentalt præparat til påvisning af plak |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing erythrosin B stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| erythrosin 6 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Antiperspirant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing permethrin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| antiseboroisk medikament |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Conventional release oromucosal solution for mouthwash (dose form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| carbamidpræparat til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| dentallægemiddel til lokal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Adverse reaction to keratolytics, keratoplastics and other hair treatment drugs and preparations |
Causative agent |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Rectal soothing preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Permethrin + pyethroid + piperonyl butoxide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Almond+arachis+camphor oil compound drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Salicylic acid [psoriasis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Salicylic acid [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Salicylic acid [callosity] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| medicinske shampooer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Scalp applications |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Shampoos [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Salicylic acid [antifungal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Soap substitutes - [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Eludril oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Minor skin infection preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Povidone [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| povidon mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,2 % mundskyllevæske med anissmag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Salicylic acid 60 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Urea 400 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,6386 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 2,5 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,12 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 1,2 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Zinksulfat 5mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Zinksulfat 25 mg/5 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| mælkesyre + salicylsyre 16,7 %wt/wt/16,7 %wt/wt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| salicylsyre gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing delmopinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| delmopinol 0,2 %, skyllevæske til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 3,15 %/isopropylalkohol 70 % vatpind til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and chlorobutanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing salicylic acid and sulfur (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| spytstimulerende tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Chlorbutol+dichlorobenz+arachis oil 5%/2%/57% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| salicylsyre 20 % 7,5 cm x 4,5 cm plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| salicylsyre 40 % 7,5 cm x 4,5 cm plaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Chlorhexidine 0.5% powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorobutanol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing lauromacrogol and urea (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing desoximetasone and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing chlorhexidine and phenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Product containing camphor and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| medicinsk tandpasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| tandpasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
|
| Debridement of wound with topical agent |
Using substance (attribute) |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
1 |
| Debridement of wound with topical agent |
Using substance (attribute) |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
1 |
| allergi over for middel til topikal anvendelse |
Causative agent |
False |
middel til topikal anvendelse |
Inferred relationship |
Some |
1 |
FHIR